1. Home
  2. NUAI vs PALI Comparison

NUAI vs PALI Comparison

Compare NUAI & PALI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo New Era Energy & Digital Inc.

NUAI

New Era Energy & Digital Inc.

HOLD

Current Price

$4.84

Market Cap

403.6M

Sector

Energy

ML Signal

HOLD

Logo Palisade Bio Inc.

PALI

Palisade Bio Inc.

N/A

Current Price

$2.03

Market Cap

359.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NUAI
PALI
Founded
N/A
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
403.6M
359.7M
IPO Year
2024
2019

Fundamental Metrics

Financial Performance
Metric
NUAI
PALI
Price
$4.84
$2.03
Analyst Decision
Buy
Strong Buy
Analyst Count
1
7
Target Price
$11.00
$11.29
AVG Volume (30 Days)
5.5M
1.5M
Earning Date
05-14-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
1.89
97.06
EPS
N/A
N/A
Revenue
$885,400.00
$260,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
66.18
1500.39
52 Week Low
$0.32
$0.55
52 Week High
$9.45
$2.86

Technical Indicators

Market Signals
Indicator
NUAI
PALI
Relative Strength Index (RSI) 45.92 49.87
Support Level $4.13 $1.58
Resistance Level $5.31 $2.20
Average True Range (ATR) 0.50 0.11
MACD -0.03 -0.01
Stochastic Oscillator 15.00 35.19

Price Performance

Historical Comparison
NUAI
PALI

About NUAI New Era Energy & Digital Inc.

New Era Energy & Digital Inc is engaged into a fully integrated energy supplier delivering next-gen digital infrastructure and power assets. The company provides turnkey solutions to speed up data center deployment and reduce costs. The company focuses on future-proofing infrastructure for hyperscale, enterprise, and edge operators. The company provide integrated energy and digital solutions to support accelerating AI infrastructure deployment and optimize data center investments.

About PALI Palisade Bio Inc.

Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.

Share on Social Networks: